Global Healthcare Fund
4 Itzhak Sadeh, Building A, 29th Floor, Tel Aviv, 6777504, Israel
Overview
Sphera Global Healthcare Management (Investment Manager) is a partnership between Mr. Mori Arkin, former vice chairman of Perrigo (Nasdaq ticker:PRGO, a world leader in generic and OTC drugs), and of Sphera Funds Management. It is a long/short equity fund that is focused on the global pharmaceutical and biotech industries. The Investment Manager’s objective is to generate consistent and attractive long term returns exceeding the industry while maintaining disciplined risk management. With a highly experienced and cohesive multidisciplinary team, the Fund’s competitive advantage is evident in three key areas: • Having a rigorous, fundamental, focused and comprehensive approach to healthcare research. • Investment committee co- led by an industry veteran with a track record of building a pharmaceutical company. • Unique and unbiased investment approach generated in part from access to massive flow of R &D, innovation and top tier human capital in Israel.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 7
Sector focus
- Financial Services
Investment portfolio
- Pinnacle Blooms
Led · Series A · Jan 2026
Pinnacle Blooms Network, the flagship pediatric-therapy enterprise of Bharath Healthcare Laboratories, delivers measurable developmental care through its multi-patent-filed Pinnacle Child Development Operating System. The platform captures and analyses data across speech, motor, cognitive, and behavioural domains, making every therapy session smarter; to date, it has powered more than 20 million sessions. The company currently operates 70 multi-disciplinary therapy centres and intends to scale to 300 centres within 24 months. Future plans include accelerating R&D for home-based TherapeuticAI applications, mass-manufacturing TherapySphere sensory rooms, and securing regulatory approvals for international markets. Management also plans geographic expansion into Southeast Asia and the GCC using its technology-enabled, measurable-outcomes approach. The freshly secured Series A capital underscores the firm’s emphasis on rapid expansion while maintaining data-driven personalisation for each child’s developmental journey.